Several new substances are attracting focus within the biomedical field. Retatrutide, a double GLP-1 and GIP agonist, is exhibiting promise for metabolic management. BPC-157, or Cor Peptide 157, is proposed to promote tissue healing, with multiple studies on its effects. GHK-Cu, a copper peptide,